Pharmaron Beijing (03759): The group collaborates with multiple companies in different fields to advance its own business development goals.

Kanglong Chemicals (03759) has issued an announcement regarding recent news reports about the Group's production cooperation with a Chinese subsidiary of an international leading pharmaceutical company. After conducting a reasonable inquiry into the matter, the company has confirmed that the aforementioned production cooperation was entered into as part of the Group's routine and normal business processes. In the course of its daily operations, the Group collaborates with multiple companies in different fields to advance its business development goals. Additionally, the company is not aware of any material that needs to be disclosed to avoid false market representation of the company's securities, nor is it aware of any insider information that must be disclosed in accordance with Listing Rule 13.09(2) and the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) Part XIVA.